Ari Raphael

Dr. Ari Raphael is a medical oncologist at Sourasky Medical Center specializing in thoracic malignancies. He is a winner of the ISCORT 17 research grant competition for his work in clinical oncology. The specialist is a member of the European Society of Medical Oncology (ESMO).

Clinical Specialization and Innovative Approach

Dr. Raphael treats lung and breast cancer. He leads the Israeli National Genomic Medicine Initiative (PSIFAS) project at Sourasky. This project applies genomics to personalize patient care. The doctor uses genomic profiling and liquid biopsies – blood tests that detect DNA from cancer cells – to monitor treatment efficacy.

The specialist serves as a moderator for the Israeli Lung Cancer Society Molecular Tumor Board. He also conducts a Next-Generation Sequencing (NGS) interpretation clinic alongside the head of pathology. These sessions help determine targeted therapies for cancer cases. Dr. Raphael treats adenocarcinoma, thymoma, and metastatic diseases.

Clinical Trials and Research Leadership

The doctor is a primary investigator for multiple phase I and III clinical trials. His research includes T-Cell Repertoire sequencing to track the efficacy of immunotherapy drugs like pembrolizumab. He also studies intra-tumoral injections involving mRNA and viruses. These trials offer patients access to biological and cell therapies.

Academic and Advisory Roles

• Senior Lecturer and researcher in Medical Education at Tel Aviv University.
• National Medical Association representative for the Council for Malignant Diseases.
• Head of the oncology field and consultant for Leumit HMO.
• Member of the Helsinki Committee for Clinical Studies at Sourasky Medical Center.
• Co-founder and treasurer of the Israeli Acute Oncology Society.
• Clinical Research Association Board of Directors member for the Israeli Lung Cancer Group.
• Member of the Trustees of Oncology Innovation at Tel Aviv Sourasky Medical Center.

Work Experience

• Head of oncology day-care service at Sourasky Medical Center.
• Consultant on drugs and oncology operations for Leumit HMO.
• Medical Service Doctor for the Israel Defense Forces (IDF).
• Oncology Resident at Tel Aviv Sourasky Medical Center.
• Executive Development Program participant in the Leader Shift program at Sourasky Medical Center.
• Sub-investigator for phase I–III clinical trials involving intra-tumoral injections of mRNA and viruses.

Education and Training

• Doctor of Medicine – Semmelweis University.
• Computational Biology degree – Bar-Ilan University, Israel.
• Genomics and Biomedical Informatics – Sheba Medical Center/Bar-Ilan University.
• Clinical observership in acute oncology – Guy's and St. Thomas Hospital, London.
• Fellowship in Health-Tech Innovation – Israeli Society for Health-Tech.
• Intensive care and pulmonology rotation – Stony Brook Hospital, New York.
• Medical school rotations – Kaplan Medical Center, Israel.

Awards and Recognition

• Winner – ISCORT 17 research grant competition.
• Outstanding Teacher – Faculty of medicine, Tel-Aviv University.
• Residency Final Examination (Shlav Beit) completed with honors.
• Sign of Honor – Reserve medical personnel, IDF.

Professional Memberships

• European Society of Medical Oncology (ESMO)
• International Association for the Study of Lung Cancer (IASLC)
• The International Society of Liquid Biopsy (ISLB)
• Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT)
• The Israeli Lung Cancer Group (ILCG)
• Israeli Medical Association (IMA)
• The Israeli Society for Health-Tech